Primary record
7-(((S)-1-(4-((S)-1-(4-acryloylpiperazin-1-yl)-2-cyclopropylethyl)phenyl)ethyl)amino)-1-ethyl-1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-one bis(2,5-dihdroxybenzoate)
- 库存
- 2,012 克
- 纯度
- 99.4 %
- CAS
- 2230263-60-0
化合物标识与属性
- CAS
- 2230263-60-0
- PubChem CID
- 135125140
- SMILES
- CCN1C2=NC(=NC=C2COC1=O)N[C@@H](C)C3=CC=C(C=C3)[C@H](CC4CC4)N5CCN(CC5)C(=O)C=C
- Canonical SMILES
- C=CC(=O)N1CCN([C@@H](CC2CC2)c2ccc([C@H](C)Nc3ncc4c(n3)N(CC)C(=O)OC4)cc2)CC1
名称与同义词
- Mutant IDH1-IN-6
- Crelosidenib
- crelosidenib [INN]
- Crelosidenib (USAN)
- RefChem:154574
- CRELOSIDENIB [USAN]
- LY3410738
- A4DU555RMD
- orb1691107
- CHEMBL6000618
- LY-3410738
- SCHEMBL20270338
- SCHEMBL29427547
- GTPL12340
- IDH1 Inhibitor LY3410738
- 2230263-60-0
- example 2 [US11001596B2]
- US11001596, Example 2
- BDBM497335
- LSN3856920
- EX-A7864
- LSN-3856920
- example 2 (US11001596B2)
- NSC832772
- IDH1 Mutant Inhibitor LY3410738
- AKOS040757436
- NSC-832772
- LY 3410738 [WHO-DD]
- LY 3410738
- DA-75820
- HY-131312
- CS-0132813
- D12708
- H61691
- A972695
- 7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-(4-prop-2-enoylpiperazin-1-yl)ethyl]phenyl]ethyl]amino]-1-ethyl-4H-pyrimido[4,5-d][1,3]oxazin-2-one
- 2H-Pyrimido[4,5-d][1,3]oxazin-2-one, 7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-[4-(1-oxo-2-propen-1-yl)-1-piperazinyl]ethyl]phenyl]ethyl]amino]-1-ethyl-1,4-dihydro-
- 7-(((1S)-1-(4-((1S)-2-cyclopropyl-1-(4-prop-2-enoylpiperazin-1-yl)ethyl)phenyl)ethyl)amino)-1-ethyl-4H-pyrimido(4,5-d)(1,3)oxazin-2-one
- 7-(((S)-1-(4-((S)-1-(4-acryloylpiperazin-1-yl)-2-cyclopropylethyl)phenyl)ethyl)amino)-1-ethyl-1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-one bis(2,5-dihdroxybenzoate)
- 7-[[(1S)-1-[4-[(1S)-2- cyclopropyl-1-(4-prop-2- enoylpiperazin-1-yl) ethyl]phenyl]ethyl]amino]- 1-ethyl-4H-pyrimido[4,5- d][1,3]oxazin-2-one